Intelligence desk

Products

Signal Tracker Data Platform Data Enrichment API

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
ASC Therapeutics logo — ASC Therapeutics develops biopharmaceuticals based on propri...

ASC Therapeutics

ASC Therapeutics develops biopharmaceuticals based on proprietary gene, CRISPR and allogeneic cell therapies

Founded 2008 United States Milpitas, United States 19 employees Biopharma, Biotechnology +1

General Information

Company Name ASC Therapeutics
Founded Year 2008
Location United States Milpitas, United States +1
Employees 19
Industries Biopharma, Biotechnology, Health Care
Social

Get notified when ASC Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ASC Therapeutics

ASC Therapeutics is a biopharmaceutical company that specializes in the development of gene, CRISPR, and allogeneic cell therapies for rare diseases. The company's focus lies in the development of curative therapies for monogenic blood disorders with high genetic penetrance and conditions requiring immunomodulatory interventions. ASC Therapeutics leverages proprietary gene editing technologies that have been developed over 12 years at Applied StemCell, a renowned life sciences company. The company's development pipeline includes several preclinical stage projects. They are actively seeking partnership opportunities to advance their groundbreaking therapies. With its deep expertise and focus on cutting-edge biotechnologies, ASC Therapeutics presents a significant opportunity for investors seeking to support innovative solutions in the biopharmaceutical space. Investors looking to enter the biopharma, biotechnology, and health care industries should consider ASC Therapeutics as a promising investment prospect. For further information and partnership opportunities, interested parties are encouraged to visit their website, www.asctherapeutics.com.

Taxonomy: Gene Therapy, Cell Therapy, CRISPR, Blood Disorders, Rare Diseases, Genome Editing, Biopharmaceuticals, Stem Cells, Clinical Research, Biotech Venture, Drug Development

No funding data available for ASC Therapeutics yet.

Get notified when ASC Therapeutics raises funding

ASC Therapeutics Alternatives & Competitors

ASC Therapeutics vs
HuidaGene Therapeutics
HuidaGene Therapeutics China

辉大，给患者回答 | Answering the Patients！

Series C
27 employees
Biopharma, Biotechnology
ASC Therapeutics vs
CRISPR Therapeutics
CRISPR Therapeutics United States

Gene-based medicines for patients with serious diseases

IPO
350 employees
Biopharma, Biotechnology
Compare ASC Therapeutics vs CRISPR Therapeutics
ASC Therapeutics vs
Modalis Therapeutics
Modalis Therapeutics United States

Modalis is an emerging biotech company that develops therapeutics using CRISPR based technology

IPO
23 employees
Biotechnology, Health Care

FAQ About ASC Therapeutics

ASC Therapeutics develops biopharmaceuticals based on proprietary gene, CRISPR and allogeneic cell therapies
ASC Therapeutics was founded in 2008.
ASC Therapeutics is headquartered in Milpitas, United States.
ASC Therapeutics operates in the following industries: Biopharma, Biotechnology, Health Care.
ASC Therapeutics has approximately 19 employees.
Top alternatives and competitors to ASC Therapeutics include HuidaGene Therapeutics, CRISPR Therapeutics, Modalis Therapeutics, Casebia Therapeutics, Acrigen Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ASC Therapeutics and HuidaGene Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ASC Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy